Skip to main content

Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview

Abstract

Aim of this commentary is to summarize the salient literature news on the relationships between autoimmune thyroid diseases (ATDs) and either Down syndrome (DS) or Turner syndrome (TS).

According to literature reports both Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are more frequent in children with DS or TS than in those without these chromosomopathies.

An up-regulation of proinflammatory cytokines might be responsible for the enhanced susceptibility of TS children to ATDs, whereas a dysregulation of immune system may favor the development of ATDs in DS.

In TS children biochemical presentation of HT is less severe than in peer controls. In both DS and TS GD picture at the time of diagnosis is not significantly different than in the pediatric general population.

The evolution over time of GD in DS and TS does not differ from that observed in the pediatric general population, whereas the evolution of HT in both TS and DS is more severe than in girls without these chromosomopathies.

Conclusions: The association with TS or DS is able to affect both epidemiology and course of ATDs by conditioning: a) an increased susceptibility to these disorders; b) a less severe biochemical presentation and a more severe evolutive pattern of HT in TS girls; c) a more severe biochemical presentation and evolution of HT in DS patients.

Background

Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) are organ-specific autoimmune disorders, that are more common in girls than in boys. In both sexes their frequency increases with age, peaking during adolescence. These autoimmune thyroid diseases (ATDs) occur more frequently in genetically susceptible children, as suggested by the higher concordance in monozygotic than dizygotic twins [1, 2], but their occurrence is also conditioned by environmental triggers, such as iodine intake [36].

Other important risk factors for ATDs are familial antecedents of autoimmune disorders, links with other extra-thyroidal autoimmune diseases and association with either Turner syndrome (TS) or Down syndrome (DS), i.e. two common chromosomopathies which are known to be frequently linked with autoimmune illnesses [7, 8].

According to the most recent literature reports, ATDs in children with either TS or DS seem to be characterized by some significant peculiarities in terms of epidemiology, pathophysiology and clinical course. These reports seem to suggest that the association with these chromosomopathies might condition peculiar phenotypical expressions of ATDs [914].

Aim of this commentary is to summarize the salient literature news concerning the relationships between ATDs and both these chromosomopathies.

Epidemiology

In pediatric age HT is a relatively common disease, whose prevalence has been estimated to fluctuate around 1.2 % [15, 16] and is distinctly higher than that reported for GD in the same age bracket, i.e. 1‰ [17] (Table 1).

Table 1 Prevalence rates of Hashimoto’s thyroiditis (HT) and Graves’ disease (GD) in the pediatric general population and in young patients with either Turner syndrome (TS) or Down syndrome (DS)

In TS girls HT is by far the most common autoimmune disorder and its prevalence has been reported to be even higher than that generally reported in age-matched girls without TS [14, 1820]. Also the prevalence rate of GD has been repeatedly reported to be distinctly higher in TS girls (from 1.7 to 3.0 %) than in the pediatric general population [13, 14, 21, 22]. Nevertheless, it is very far from that of HT in TS, which is generally reported to range from 10 to 21 % [14, 22, 23] (Table 1).

Also in DS children the prevalence rates of both HT (13–34 %) [24, 25] and GD (6.5‰) [11] are known to be distinctly higher than in the pediatric general population (Table 1).

On overall, on the basis of literature reports, it may be pointed out that both HT and GD are more frequent in the young patients with either TS or DS than in those without these chromosomopathies (Table 1).

Pathophysiological interpretation of these epidemiological findings

Although it is well assessed, on the basis of the above epidemiological reports, that young patients with TS and DS are more prone to develop ATDs, the pathophysiological mechanisms of these links have not been completely elucidated to date. Nevertheless, in the case of TS children, this association might be, at least partially, explained in the light of the generally recognized links between thyroid autoimmunity and female gender [14]. Another likely and very simple explanation might be that many pediatricians are aware that both TS and DS children are more incline to the risk of developing ATDs and also other autoimmune extra-thyroidal disorders, such as celiac disease, type 1 diabetes, vitiligo and juvenile idiopathic arthritis [19, 26]. Consequently, HT and GD in these conditions might be sometimes suspected by pediatricians even in the presence of minimal thyroid dysfunction symptoms and/or signs [10] and the finding of a thyroid enlargement in these children might be probably considered with more attention. Such an explanation seems to be supported by the observation that ATDs in DS children are generally diagnosed at a younger age than in those without DS [11, 12, 27].

In TS it has been hypothesized that the increased susceptibility to ATDs might be associated with haploinsufficiency of the genes in the pseudoautosomal region of the X-chromosome [26, 28], that may play a relevant part in the pathogenesis of autoimmune diseases [23]. According to other reports, the risk of ATDs is especially high in the patients with X-isochromosome [14, 29, 30], thus suggesting that a gene on the long arm of X-chromosome might be involved in conditioning the predisposition towards ATDs [30]. Other authors, in contrast, have not reported any significant relationships between ATDs and a specific karyotype [13, 22, 31, 32]. Therefore, in the light of the conflicting literature data, no definitive conclusions can be drawn about the influence of karyotype on thyroid autoimmunity in TS.

Other features of TS phenotype, such as an up-regulation of proinflammatory cytokines, might be, at least partially, responsible for the enhanced susceptibility of TS patients to ATDs [33].

In DS the increased prevalence of ATDs has been recently attributed to a dysregulation of immune system [34], with consequent defect of inhibitory activity. These alterations may favor the development of ATDs and other autoimmune disorders [35].

Clinical and biochemical presentation

Although there are in pediatric literature several studies on the relationships between either TS or DS and ATDs, only few of them have specifically addressed the intriguing issue whether the association with these chromosomal aberrations may in any way condition a different presentation mode of ATDs in pediatric age.

A very peculiar anamnestic feature of GD in both TS and DS children is that its presentation in these conditions is often (20 % of cases) preceded by HT antecedents [9]. It had been already demonstrated that, even in the pediatric general population, there exists a continuum between HT and GD within the spectrum of ATDs [3640]. The specific observation that children with TS or DS are more likely to progress from HT to GD suggests that the association with these chromosomopathies might favor such a metamorphosis [9].

In DS patients GD does not demonstrate any gender predominance, as against as generally observed in the patients without DS [12]. This finding confirms that children with DS are per se more exposed to the risk of developing GD, irrespective of other concomitant risk factors [12].

In both these chromosomopathies clinical and biochemical picture of GD at the time of diagnosis is not significantly different from that observed in the pediatric general population [12, 13].

In DS children the most common biochemical patterns at HT presentation are subclinical hypothyroidism (SH) and overt hypothyroidism, whereas euthyroidism is distinctly less common than in HT children without DS [41]. In contrast, according to a very recent study, thyroid function impairment at HT presentation seems to be significantly less severe than in girls without TS [10], as substantiated by the higher prevalence of euthyroidism and the lower prevalence rates of both overt hypothyroidism and hyperthyroidism (Table 2). Moreover, in TS girls median TSH serum levels were reported to be significantly lower than in sex-matched peer controls [10]. The less severe impairment of thyroid function at HT presentation in TS children might be explained on the basis of a less aggressive autoimmune pattern [10].

Table 2 Prevalence rates (%) of the different thyroid function patterns at Hashimoto’s thyroiditis (HT) presentation in the pediatric general population and in children with Turner syndrome (TS) or Down syndrome (DS), according to our data

Table 2 summarizes the prevalence rates of the different thyroid function patterns by us detected at HT presentation in children with TS and DS and in age-matched children without these chromosomopathies.

Clinical and biochemical evolution over time

Clinical and biochemical evolution under methimazole therapy has been specifically investigated in two studies aiming at ascertaining whether GD children with either DS or TS may exhibit different responses to pharmacological therapy, with respect to young patients without these chromosomopathies [12, 13].

In DS patients the course of GD under methimazole treatment seems to be less severe than in the children without DS [12]. This inference, however, is in contrast with the results of another study on the same issue, according to which the remission rates under pharmacological therapy are very low in DS-related GD and many DS patients with GD may need radioiodine ablation [11].

In TS children both the initial methimazole doses and those needed to maintain euthyroidism during the first treatment cycle were not different than in girls without TS [13]. Also remission rates during the first methimazole cycle, relapse rates after the first cycle withdrawal and cumulative incidences of relapse were reported to not differ than in GD girls without TS. Finally, even the rates of girls who need a non-pharmacological treatment, such as surgery or radioiodine ablation, do not seem to be significantly higher in GD girls with TS [13]. Therefore, according to the only available study aiming at comparing clinical and biochemical responses to therapy in two different series of GD girls with or without TS [13], it may be argued that the evolution over time of GD does not significantly differ in the children with TS than in those without TS.

The spontaneous evolution over time of thyroid function tests in TS children with HT has been only occasionally evaluated so far [10, 14]. According to these reports, such course seems to be characterized by a spontaneous deterioration of thyroid function [13, 14]. In fact, thyroid tests were reported to significantly worsen over time, both in the girls who had presented with euthyroidism and in the ones who had presented with thyroid dysfunctions and this spontaneous trend seems to be irrespective of both karyotype and other factors [10]. Thyroid function deterioration over time seems to be especially evident in the TS girls with initial SH [10]. These findings are particularly striking considering that the natural history of SH in the pediatric population had been so far reported to be generally characterized by a less negative spontaneous trend, both in the cases with an idiopathic form [4247] and in the ones with an underlying HT [10, 4850]. To sum up, in the light of these peculiarities which seem to characterize the natural history of TS-related HT, a strict monitoring of thyroid function has to be strongly suggested in these patients [10].

A close monitoring of thyroid tests during follow-up has probably to be suggested also in the children with DS-related HT, at least according to the results of a very recent follow-up study on this specific issue [41]. Moreover, it is well known that the association with DS may sometimes condition a particularly severe clinical expression of autoimmunity [51].

Influence of the genes affected by TS and DS

There are at least ten genes located on the X-chromosome which are known to be possibly involved in the immuneregulation process [28]. The most important one is FOXP3, that encodes a transcription factor for the function of regulatory T-cells. Its deletion causes immunodysregulation, polyendocrinopathy and X-linked enteropathy [28]. Polymorphisms of this gene are associated with AITDs in Caucasian people [52], thus suggesting that FOXP3 haploinsufficiency might be responsible for the increased risk of AITDs in TS girls [28].

In DS the predisposition to autoimmunity may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE gene, which is located on chromosome 21 [53]. According to this view, the thymus of DS patients might contain significantly lower levels of AIRE gene, which may in turn condition the predisposition to autoimmunity that is typical of DS [53].

Conclusions

The association with TS or DS is able to affect both epidemiology and course of AITDs by conditioning: a) an increased susceptibility to these disorders; b) a more frequent shifting from HT to GD; c) a less severe biochemical presentation and a more severe evolutive pattern of HT in TS girls; d) a more severe biochemical presentation and evolution of HT in DS patients.

Abbreviations

HT:

Hashimoto’s thyroiditis

GD:

Graves’ disease

ATDs:

Autoimmune thyroid diseases

TS:

Turner syndrome

DS:

Down syndrome

SH:

Subclinical hypothyroidism

References

  1. Hemminki K, Li X, Sundquist J, Sundquist K. The epidemiology of Graves’ disease: evidence of a genetic and an environmental contribution. J Autoimmun. 2010;34:J307–13.

    Article  CAS  PubMed  Google Scholar 

  2. Brix TH, Hegedüs L. Twin studies as a model for exploring the aetiology of autoimmune thyroid disease. Clin Endocrinol. 2012;76:457–64.

    Article  CAS  Google Scholar 

  3. Zois C, Stavrou I, Kalogera C, Svarna E, Dimoliatis I, Seferiadis K, et al. High prevalence of autoimmune thyroiditis in schoolchildren after elimination of iodine deficiency in northwestern Greece. Thyroid. 2003;13:485–9.

    Article  PubMed  Google Scholar 

  4. Yang F, Shan Z, Teng X, Li Y, Guan H, Chong W, et al. Chronic iodine excess does not increase the incidence of hyperthyroidism: a prospective community-based epidemiological survey in China. Eur J Endocrinol. 2007;156:403–8.

    Article  CAS  PubMed  Google Scholar 

  5. Ergür AT, Evliyaoğlu O, Şıklar Z, Bilir P, Öcal G, Berberoğlu M. Evaluation of thyroid functions with respect to iodine status and TRH test in chronic autoimmune thyroiditis. J Clin Res Pediatr Endocrinol. 2011;3:18–21.

    Article  PubMed Central  PubMed  Google Scholar 

  6. Laurberg P, Cerqueira C, Ovesen L, Rasmussen LB, Perrild H, Andersen S, et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab. 2010;24:13–27.

    Article  CAS  PubMed  Google Scholar 

  7. Lleo A, Moroni L, Caliari L, Invernizzi P. Autoimmunity and Turner’s syndrome. Autoimmun Rev. 2012;11:A538–43.

    Article  CAS  PubMed  Google Scholar 

  8. Roizen NJ, Patterson D. Down’s syndrome. Lancet. 2003;361:1281–9.

    Article  PubMed  Google Scholar 

  9. Aversa T, Lombardo F, Corrias A, Salerno M, De Luca F, Wasniewska M. In young patients with Turner or Down syndrome, Graves’ disease presentation is often preceded by Hashimoto’s thyroiditis. Thyroid. 2014;24:744–7.

    Article  CAS  PubMed  Google Scholar 

  10. Aversa T, Messina MF, Mazzanti L, Salerno M, Mussa A, Faienza MF, et al. The association with Turner syndrome significantly affects the course of Hashimoto’s thyroiditis in children, irrespective of karyotype. Endocrine. 2014. doi:10.1007/s12020-014-0513-6 (Epub ahead of print).

    PubMed  Google Scholar 

  11. Goday-Arno A, Cerda-Esteva M, Flores-Le-Roux JA, Chillaron-Jordan JJ, Corretger JM, Cano-Pérez JF. Hyperthyroidism in a population with Down syndrome (DS). Clin Endocrinol. 2009;71:110–4.

    Article  CAS  Google Scholar 

  12. De Luca F, Corrias A, Salerno M, Wasniewska M, Gastaldi R, Cassio A, et al. Peculiarities of Graves’ disease in children and adolescents with Down’s syndrome. Eur J Endocrinol. 2010;162:591–5.

    Article  PubMed  Google Scholar 

  13. Valenzise M, Aversa T, Corrias A, Mazzanti L, Cappa M, Ubertini G, et al. Epidemiology, presentation and long-term evolution of Graves’ disease in children, adolescents and young adults with Turner syndrome. Horm Res Paediatr. 2014;81:245–50.

    CAS  PubMed  Google Scholar 

  14. Livadas S, Xekouki P, Fouka F, Kanaka-Gantenbein C, Kaloumenou I, Mavrou A, et al. Prevalence of thyroid dysfunction in Turner’s syndrome: a long-term follow-up study and brief literature review. Thyroid. 2005;15:1061–6.

    Article  CAS  PubMed  Google Scholar 

  15. Rallison ML, Dobyns BM, Keating FR, Rall JE, Tyler FH. Occurrence and natural history of chronic lymphocytic thyroiditis in childhood. J Pediatr. 1975;86:675–82.

    Article  CAS  PubMed  Google Scholar 

  16. Tozzoli R, Perini R. Malattie autoimmuni nei primi anni di vita: dai sintomi alla diagnosi di laboratorio. La Rivista Italiana della Medicina di Laboratorio – Italian Journal of. Lab Med. 2007;3:45–50.

    Google Scholar 

  17. Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2:119–25.

    Article  PubMed  Google Scholar 

  18. Fukuda I, Hizuka N, Kurimoto M, Morita J, Tanaka S, Yamakado Y, et al. Autoimmune thyroid diseases in 65 Japanese women with Turner syndrome. Endocr J. 2009;56:983–6.

    Article  PubMed  Google Scholar 

  19. Larizza D, Calcaterra V, Martinetti M. Autoimmune stigmata in Turner syndrome: when lacks an X chromosome. J Autoimmun. 2009;33:25–30.

    Article  CAS  PubMed  Google Scholar 

  20. Grossi A, Crinò A, Luciano R, Lombardo A, Cappa M, Fierabracci A. Endocrine autoimmunity in Turner syndrome. Ital J Pediatr. 2013;39:79.

    Article  PubMed Central  PubMed  Google Scholar 

  21. Wasniewska M, Corrias A, Messina MF, Crisafulli G, Salzano G, Valenzise M, et al. Graves’ disease prevalence in a young population with Turner syndrome. J Endocrinol Invest. 2010;33:69–70.

    Article  CAS  PubMed  Google Scholar 

  22. Radetti G, Mazzanti L, Paganini C, Bernasconi S, Russo G, Rigon F, et al. Frequency, clinical and laboratory features of thyroiditis in girls with Turner’s syndrome. The Italian Study Group for Turner’s Syndrome. Acta Paediatr. 1995;84:909–12.

    Article  CAS  PubMed  Google Scholar 

  23. Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, et al. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol. 2005;175:575–8.

    Article  CAS  PubMed  Google Scholar 

  24. Karlsson B, Gustafsson J, Hedov G, Ivarsson SA, Annerén G. Thyroid dysfunction in Down’s syndrome: relation to age and thyroid autoimmunity. Arch Dis Child. 1998;79:242–5.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  25. Popova G, Paterson WF, Brown A, Donaldson MD. Hashimoto’s thyroiditis in Down’s syndrome: clinical presentation and evolution. Horm Res. 2008;70:278–84.

    Article  CAS  PubMed  Google Scholar 

  26. Jørgensen KT, Rostgaard K, Bache I, Biggar RJ, Nielsen NM, Tommerup N, et al. Autoimmune diseases in women with Turner’s syndrome. Arthritis Rheum. 2010;62:658–66.

    Article  PubMed  Google Scholar 

  27. Shalitin S, Phillip M. Autoimmune thyroiditis in infants with Down’s syndrome. J Pediatr Endocrinol Metab. 2002;15:649–52.

    PubMed  Google Scholar 

  28. Bakalov VK, Gutin L, Cheng CM, Zhou J, Sheth P, Shah K, et al. Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency. J Autoimmun. 2012;38:315–21.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Chiovato L, Larizza D, Bendinelli G, Tonacchera M, Marinó M, Mammoli C, et al. Autoimmune hypothyroidism and hyperthyroidism in patients with Turner’s syndrome. Eur J Endocrinol. 1996;134:568–75.

    Article  CAS  PubMed  Google Scholar 

  30. Elsheikh M, Wass JA, Conway GS. Autoimmune thyroid syndrome in women with Turner’s syndrome–the association with karyotype. Clin Endocrinol. 2001;55:223–6.

    Article  CAS  Google Scholar 

  31. Gawlik A, Gawlik T, Januszek-Trzciakowska A, Patel H, Malecka-Tendera E. Incidence and dynamics of thyroid dysfunction and thyroid autoimmunity in girls with Turner’s syndrome: a long-term follow-up study. Horm Res Paediatr. 2011;76:314–20.

    Article  CAS  PubMed  Google Scholar 

  32. El-Mansoury M, Bryman I, Berntorp K, Hanson C, Wilhelmsen L, Landin-Wilhelmsen K. Hypothyroidism is common in turner syndrome: results of a five-year follow-up. J Clin Endocrinol Metab. 2005;90:2131–5.

    Article  CAS  PubMed  Google Scholar 

  33. Gravholt CH, Hjerrild BE, Mosekilde L, Hansen TK, Rasmussen LM, Frystyk J, et al. Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules. Eur J Endocrinol. 2006;155:583–92.

    Article  CAS  PubMed  Google Scholar 

  34. Pellegrini FP, Marinoni M, Frangione V, Tedeschi A, Gandini V, Ciglia F, et al. Down syndrome, autoimmunity and T regulatory cells. Clin Exp Immunol. 2012;169:238–43.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  35. Ram G, Chinen J. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol. 2011;164:9–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  36. Ludgate M, Emerson CH. Metamorphic thyroid autoimmunity. Thyroid. 2008;18:1035–7.

    Article  PubMed  Google Scholar 

  37. Wasniewska M, Corrias A, Arrigo T, Lombardo F, Salerno M, Mussa A, et al. Frequency of Hashimoto’s thyroiditis antecedents in the history of children and adolescents with graves’ disease. Horm Res Paediatr. 2010;73:473–6.

    Article  CAS  PubMed  Google Scholar 

  38. Kamath C, Young S, Kabelis K, Sanders J, Adlan MA, Furmaniak J, et al. Thyrotrophin receptor antibody characteristics in a woman with long-standing Hashimoto’s who developed Graves’ disease and pretibial myxoedema. Clin Endocrinol. 2012;77:465–70.

    Article  CAS  Google Scholar 

  39. Troisi A, Novati P, Sali L, Colzani M, Monti G, Cardillo C, et al. Graves’ thyrotoxicosis following Hashimoto’s thyroiditis. Res Rep Endocr Disord. 2013;3:13–5.

    Google Scholar 

  40. Champion B, Gopinath B, Ma G, El-Kaissi S, Wall JR. Conversion to Graves’ hyperthyroidism in a patient with hypothyroidism due to Hashimoto’s thyroiditis documented by real-time thyroid ultrasonography. Thyroid. 2008;18:1135–7.

    Article  PubMed  Google Scholar 

  41. Aversa T, Salerno M, Radetti G, Faienza MF, Iughetti L, Corrias A, et al. Peculiarities of presentation and evolution over time of Hashimoto’s thyroiditis in children and adolescents with Down’s syndrome. Hormones 2015 in press, accepted for publication on February, 19, 2015.

  42. Niedziela M. Subclinical hypothyroidism: dilemmas in the treatment of children. J Endocrinol Invest. 2007;30:529–31.

    Article  CAS  PubMed  Google Scholar 

  43. Wasniewska M, Salerno M, Cassio A, Corrias A, Aversa T, Zirilli G, et al. Prospective evaluation of the natural course of idiopathic subclinical hypothyroidism in childhood and adolescence. Eur J Endocrinol. 2009;160:417–21.

    Article  CAS  PubMed  Google Scholar 

  44. De Luca F, Wasniewska M, Zirilli G, Aversa T, Arrigo T. At the end of a two-year follow-up elevated TSH levels normalize or remain unchanged in most the children with subclinical hypothyroidism. Ital J Pediatr. 2010;36:11.

    Article  PubMed Central  PubMed  Google Scholar 

  45. Cerbone M, Bravaccio C, Capalbo D, Polizzi M, Wasniewska M, Cioffi D, et al. Linear growth and intellectual outcome in children with long-term idiopathic subclinical hypothyroidism. Eur J Endocrinol. 2011;164:591–7.

    Article  CAS  PubMed  Google Scholar 

  46. Wasniewska M, Corrias A, Salerno M, Mussa A, Capalbo D, Messina MF, et al. Thyroid function patterns at Hashimoto’s thyroiditis presentation in childhood and adolescence are mainly conditioned by patients’ age. Horm Res Paediatr. 2012;78:232–6.

    Article  CAS  PubMed  Google Scholar 

  47. De Luca F, Corica D, Pitrolo E, Santucci S, Romeo M. Idiopathic and mild subclinical hypothyroidism in childhood: clinical management. Minerva Pediatr. 2014;66:63–8.

    PubMed  Google Scholar 

  48. Monzani A, Prodam F, Rapa A, Moia S, Agarla V, Bellone S, et al. Endocrine disorders in childhood and adolescence. Natural history of subclinical hypothyroidism in children and adolescents and potential effects of replacement therapy: a review. Eur J Endocrinol. 2012;168:R1–11.

    Article  PubMed  Google Scholar 

  49. Radetti G, Maselli M, Buzi F, Corrias A, Mussa A, Cambiaso P, et al. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol. 2012;76:394–8.

    Article  CAS  Google Scholar 

  50. Bona G, Prodam F, Monzani A. Subclinical hypothyroidism in children: natural history and when to treat. J Clin Res Pediatr Endocrinol. 2013;5 Suppl 1:23–8.

    PubMed Central  PubMed  Google Scholar 

  51. Salzano G, Lombardo F, Arrigo T, Sferlazzas C, Wasniewska M, Valenzise M, et al. Association of five autoimmune diseases in a young woman with Down’s syndrome. J Endocrinol Invest. 2010;33:202–3.

    Article  CAS  PubMed  Google Scholar 

  52. Ban Y, Tozaki T, Tobe T, Ban Y, Jacobson EM, Concepcion ES, et al. The regulatory T cell gene FOXP3 and genetic susceptibility to thyroid autoimmunity: an association analysis in Caucasian and Japanese cohorts. J Autoimmun. 2007;28:201–7.

    Article  CAS  PubMed  Google Scholar 

  53. Giménez-Barcons M, Casteràs A, Armengol Mdel P, Porta E, Correa PA, Marín A, et al. Autoimmune predisposition in Down syndrome may result from a partial central tolerance failure due to insufficient intrathymic expression of AIRE and peripheral antigens. J Immunol. 2014;193:3872–9.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Filippo De Luca.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

FDL has given final approval of the version to be published; TA and MW has been involved in revising the manuscript for important intellectual outcome; FL and MV have given substantial contributions to conception and design; MFM and CS have given substantial contribution to acquisition, analysis and interpretation of data; GS has been involved in drafting the manuscript and looking for the most suitable references. All authors read and approved the final manuscript.

Rights and permissions

Open Access  This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.

The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/.

The Creative Commons Public Domain Dedication waiver (https://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Aversa, T., Lombardo, F., Valenzise, M. et al. Peculiarities of autoimmune thyroid diseases in children with Turner or Down syndrome: an overview. Ital J Pediatr 41, 39 (2015). https://doi.org/10.1186/s13052-015-0146-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13052-015-0146-2

Keywords